Podcast: NEUROLOGY PODCAST
Neurology® Podcast Clinical Criteria for LATE
Dr. Greg Cooper talks with Dr. David A. Wolk about limbic predominant age-related TDP-43 encephalopathy (LATE) discussing its clinical features, diagnostic criteria, and the importance of recognizing this condition in the context of Alzheimer disease….
Read MoreNeurology® Podcast False Positivity of Acetylcholine Receptor Autoantibodies in Clinical Practice
Dr. Stacey Clardy talks with Dr. Elia Sechi about the importance of understanding lab test results, the performance characteristics of assays, and the real-world implications of false positives in myasthenia gravis testing. Read the related article in…
Read MoreNeurology® Podcast Transforming Neurology Education: Evaluating Teaching Incentive Programs
Dr. Roy E. Strowd talks with Dr. Susannah Cornes about a teaching incentive initiative designed to support and reward faculty in academic neurology. Read the related article in . Disclosures can be found at .
Read MoreNeurology® Podcast Body-First Lewy Body Disease Observed in Postmortem Tissue from Prediagnostic Individuals
Dr. Jeff Ratliff talks with Dr. Per Borghammer about the classification of Lewy body disease into brain-first and body-first subtypes, with a focus on the newly identified parasympathetic and sympathetic subtypes within the body-first category. …
Read MoreNeurology® Podcast 2025 AAN President’s Award Recipient – Dr. Janis Miyasaki
Dr. Stacey Clardy talks with Dr. Janis Miyasaki about her journey into neurology, the integration of palliative care into neurologic practice, and the critical importance of patient-centered care. Read more about the . Disclosures can be found…
Read MoreNeurology® Podcast Spontaneous Intracranial Hypotension Updates
Dr. Jessica Ailani talks with Dr. Kathleen Digre about the evolution of spontaneous intracranial hypotension (SIH) diagnosis and treatment over the past decade. Disclosures can be found at .
Read MoreNeurology® Podcast Understanding Blood-Based Biomarkers in Alzheimer Disease
Dr. Dan Ackerman talks with Dr. Trey Bateman about the significance of blood-based biomarkers in Alzheimer disease. to get access to the recordings and the ability to claim CME through March 1, 2026. Disclosures can be found at .
Read MoreNeurology® Podcast May 2025 Recall: Topics on Myasthenia Gravis
The May 2025 recall features four previously posted episodes on myasthenia gravis. The first episode has Dr. Fredrik Piehl discussing rituximab for new-onset generalized MG. In the second episode, Dr. Vera Bril explores the potential use of…
Read MoreNeurology® Podcast Diagnosis of Alzheimer Disease Using Plasma Biomarkers
Dr. Greg Cooper talks with Dr. Joseph Therriault about the use of plasma biomarkers in diagnosing Alzheimer disease, emphasizing the importance of interpreting these biomarkers within the clinical context of the patient. Read the related article…
Read More